Chronic Kidney Disease as an Independent Risk Factor for Thromboembolism in Patients with Atrial Fibrillation

Gyu-Chul OH; Myung-Jin CHA; Do-Yoon KANG; Ji-Yeong KIM; Young-Jun SUNG; Jung-Han YOON; Dong-Won LEE; Min-Ho LEE; Wonseok CHOE; Eue-Keun CHOI; Seil OH.
Korean Journal of Medicine ; : 464-469, 2011.
Artículo en Ko | WPRIM | ID: wpr-169346

Documentos relacionados

  1. Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve.
  2. [Basic Principles of Periprocedural Management of Patients With Nonvalvular Atrial Fibrillation Receiving Anticoagulant Therapy: the Consensus Document of Experts of the American College of Cardiology].
  3. Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic-TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions.
  4. Systematic review of warfarin-induced skin necrosis case reports and secondary analysis of factors associated with mortality.
  5. Clinical Outcomes of Different Warfarin Self-Care Strategies: A Systematic Review and Network Meta-Analysis.
  6. Response.
  7. Vitamin K: A new guardian against ferroptosis.
  8. Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic.
  9. Anticoagulation versus placebo for heart failure in sinus rhythm.
  10. The Impact of Pharmacist-Managed Service on Warfarin Therapy in Patients after Mechanical Valve Replacement.